Royalty Pharma Plc  (RPRX)
Other Ticker:  


RPRX's Dividend Pay out ratio over the 12 Months Period

Cumulative by Quarter, Trailing twelve months

According to the latest data Mar 31 2024, it is not possible to calculate dividend pay out ratio.
Visit Royalty Pharma Plc Cash flow

Dividend in Glossary

Cumulative Dividend Pay out Ratio I. Quarter
(Mar 31 2024)
IV. Quarter
(Dec 31 2023)
III. Quarter
(Sep 30 2023)
II. Quarter
(Jun 30 2023)
I. Quarter
(Mar 31 2023)
RPRX's Pay out Ratio (TTM) - - - - -
RPRX's Dividend Pay out Ratio Total Ranking # # # # #

  News about Royalty Pharma Plc Dividends

Royalty Pharma Approves Dividend Payout - Boosting Shareholder Confidence

NEW YORK, April 17, 2024 - Royalty Pharma plc (Nasdaq: RPRX), a leading biopharmaceutical investment company, announced today that its board of directors has approved the payment of a dividend for the second quarter of 2024. Shareholders can expect to receive $0.21 per Class A ordinary share as a result of this decision. This news comes at a crucial time for the company, as it strives to maintain investor confidence amidst recent market fluctuations.
In order to understand the significance of this dividend, it is important to put it into context with recent news. On October 16, 2023, Royalty Pharma Plc faced declining stock performance and a negative investor sentiment. During the preceding 30 days at that time, the stock declined by -6.18%, bringing the share price down by 2.77% in the past 90 days. The stock was also trading only 8.9% above its 52-week low.

Boosting Investor Confidence: Royalty Pharma PLC Growth Portrayed by a 5% Dividend Increase in Q1 2024

In a move that offers a fresh demonstration of its robust financial health and rewarding commitment to shareholders, global leader in drug royalty acquisitions, Royalty Pharma plc (RPRX), has declared a dividend of $0.21 per Class A share for Q1 2024.
In an official statement released today, the company announced that its board of directors approved the payout, signalling a 5% dividend increase from the previous quarter. This strategic decision upholds the findings of a thorough analysis conducted last year - On 2023-10-16 Dividends and Declines: Assessing Royalty Pharma PLC's Stock Performance and Investor Sentiment.

Dividends and Declines: Assessing Royalty Pharma PLC's Stock Performance and Investor Sentiment

In a recent press release, Royalty Pharma PLC announced the declaration of a dividend for the fourth quarter of 2023. The board of directors approved a dividend payment of $0.20 per Class A ordinary share. This article aims to outline the key facts from the press release and analyze their potential impact on the company's stock performance.
Outlining the Facts:
1. Dividend Declaration:
The board of directors of Royalty Pharma PLC has authorized the payment of a dividend of $0.20 per Class A ordinary share for the fourth quarter of 2023. This decision highlights the company's commitment to shareholder value and rewarding investors through regular dividend distributions.

RPRX's Dividend Pay out Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
S&P 500 #

Dividend Pay out Ratio Statistics
High Average Low
0 % 0 % 0 %

Other Dividend Ratios
Highest Ranking Dividend Yield
Lowest Ranking Dividend Yield
Annual Dividend Pay out for RPRX
RPRX's Dividend Yield


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com